In essence, decentralization depends on ecosystem-wide changes. “I believe we are at a crossroads in the cell and gene therapy industry,” Åmellem says.

Under this agreement, BCA’s national network of blood centers will provide decentralized manufacturing services for Galapagos’ CAR-T cell therapy product candidates, close to cancer treatment ...

This week’s episode of “The Top Line,” is the final part of a three-part series diving into the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s ...

Lonza’s platform for autologous cell therapy manufacturing, the Cocoon, is a functionally closed, automated system that is currently being used to support clinical trials in Europe and North America, ...

To keep pace with expected T-cell therapy approvals—up to 20 each year by 2025—manufacturers must gain the ability to produce millions of doses.

This week’s episode of “The Top Line” is the second part of a three-part series exploring the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s ...

Cell Therapy Manufacturing Operation To Expand In Maryland Kite will build a 70,000-square-foot raw materials warehouse next to its existing facility in Frederick County, adding 100 jobs. 01/11/2023 ...

ANN ARBOR, Mich., June 24, 2025 /PRNewswire/ -- Akadeum Life Sciences, the world leader in advanced cell separation technology, proudly announces a groundbreaking workflow that leverages its ...

Excellos Inc., a cell therapy contract and development manufacturing organization member of Blood Centers of America, today announced that it has been selected to manufacture Galapagos’ CAR-T ...

Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area Oct. 01, 2024 6:00 AM ET ...